MADIT-RIT
Multicenter Automatic Defibrillator Implantation Trial
Reduce Inappropriate Therapy


Boston Scientific is excited to provide you with the results of the MADIT RIT trial presented November 6th, 2012 during the Late Breaking session at the American Heart Association meeting in Los Angeles and published in the New England Journal of Medicine. This prospective randomized trial of 1500 patients was designed to determine if alternate (improved) programming could reduce the occurrence of inappropriate therapy (shock or ATP) in primary prevention patients with a dual-chamber ICD or CRT-D device.


Results

In the MADIT RIT trial, when improved programming was used, patients were more likely to receive therapy only when needed.

  • The improved programming reduced the risk of inappropriate therapy by 76-79% when compared to conventional programming (p<0.001; HR=0.24;0.21 respectively).
  • Risk of death was decreased by 44-55% for patients who received the improved programming when compared to conventional programming. (p= 0.06; HR=0.56; p=0.01 HR=0.45 respectively).

 

 

 Survival Propability Graph from NEJM

 

Important Safety Information

 

Media Resources Button

1. Moss AJ, Hall, WJ, Cannom DS, Klein H, Brown MW et al. NEJM published online November 6th, 2012.

MADIT RIT press release Nov 6, 2012. http://bostonscientific.mediaroom.com/press-releases.

CRM-120107-AA NOV 2012

TRUSTe European Safe Harbor certification